世界の肝疾患治療薬市場：市場規模・現状・予測

• 英文タイトル：Global Liver Diseases Therapeutics Drugs Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7467 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当資料は、肝疾患治療薬のグローバル市場について調査・分析したレポートで、種類別（経口、注入）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・肝疾患治療薬の世界市場規模 ・主要企業別市場シェア ・肝疾患治療薬の世界市場規模：種類別（経口、注入） ・肝疾患治療薬の世界市場規模：用途別（病院、診療所、その他） ・肝疾患治療薬のアメリカ市場規模（種類別、用途別） ・肝疾患治療薬のヨーロッパ市場規模（種類別、用途別） ・肝疾患治療薬の中国市場規模（種類別、用途別） ・肝疾患治療薬の日本市場規模（種類別、用途別） ・肝疾患治療薬の東南アジア市場規模（種類別、用途別） ・肝疾患治療薬のインド市場規模（種類別、用途別） ・肝疾患治療薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・肝疾患治療薬の世界市場予測（2019年-2025年） ・肝疾患治療薬の地域別市場予測（2019年-2025年） ...

In 2018, the global Liver Diseases Therapeutics Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Liver Diseases Therapeutics Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Liver Diseases Therapeutics Drugs development in United States, Europe and China.

The key players covered in this study
F. Hoffmann-La Roche
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Achillion Pharmaceuticals
AbbVie
Angion Biomedica
Bayer
LG Life Sciences
Phenex Pharmaceuticals
ProMetic Life Sciences
Raptor Pharmaceuticals
Shenzhen Kangtai Biological Products
Verva Pharmaceuticals

Market segment by Type, the product can be split into
Oral
Injection

Market segment by Application, split into
Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Liver Diseases Therapeutics Drugs status, future forecast, growth opportunity, key market and key players.
To present the Liver Diseases Therapeutics Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Liver Diseases Therapeutics Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Liver Diseases Therapeutics Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Liver Diseases Therapeutics Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Liver Diseases Therapeutics Drugs Market Size
2.2 Liver Diseases Therapeutics Drugs Growth Trends by Regions
2.2.1 Liver Diseases Therapeutics Drugs Market Size by Regions (2014-2025)
2.2.2 Liver Diseases Therapeutics Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Liver Diseases Therapeutics Drugs Market Size by Manufacturers
3.1.1 Global Liver Diseases Therapeutics Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Liver Diseases Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Liver Diseases Therapeutics Drugs Key Players Head office and Area Served
3.3 Key Players Liver Diseases Therapeutics Drugs Product/Solution/Service
3.4 Date of Enter into Liver Diseases Therapeutics Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Liver Diseases Therapeutics Drugs Market Size by Type (2014-2019)
4.2 Global Liver Diseases Therapeutics Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Liver Diseases Therapeutics Drugs Market Size (2014-2019)
5.2 Liver Diseases Therapeutics Drugs Key Players in United States
5.3 United States Liver Diseases Therapeutics Drugs Market Size by Type
5.4 United States Liver Diseases Therapeutics Drugs Market Size by Application

6 Europe
6.1 Europe Liver Diseases Therapeutics Drugs Market Size (2014-2019)
6.2 Liver Diseases Therapeutics Drugs Key Players in Europe
6.3 Europe Liver Diseases Therapeutics Drugs Market Size by Type
6.4 Europe Liver Diseases Therapeutics Drugs Market Size by Application

7 China
7.1 China Liver Diseases Therapeutics Drugs Market Size (2014-2019)
7.2 Liver Diseases Therapeutics Drugs Key Players in China
7.3 China Liver Diseases Therapeutics Drugs Market Size by Type
7.4 China Liver Diseases Therapeutics Drugs Market Size by Application

8 Japan
8.1 Japan Liver Diseases Therapeutics Drugs Market Size (2014-2019)
8.2 Liver Diseases Therapeutics Drugs Key Players in Japan
8.3 Japan Liver Diseases Therapeutics Drugs Market Size by Type
8.4 Japan Liver Diseases Therapeutics Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Liver Diseases Therapeutics Drugs Market Size (2014-2019)
9.2 Liver Diseases Therapeutics Drugs Key Players in Southeast Asia
9.3 Southeast Asia Liver Diseases Therapeutics Drugs Market Size by Type
9.4 Southeast Asia Liver Diseases Therapeutics Drugs Market Size by Application

10 India
10.1 India Liver Diseases Therapeutics Drugs Market Size (2014-2019)
10.2 Liver Diseases Therapeutics Drugs Key Players in India
10.3 India Liver Diseases Therapeutics Drugs Market Size by Type
10.4 India Liver Diseases Therapeutics Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Liver Diseases Therapeutics Drugs Market Size (2014-2019)
11.2 Liver Diseases Therapeutics Drugs Key Players in Central & South America
11.3 Central & South America Liver Diseases Therapeutics Drugs Market Size by Type
11.4 Central & South America Liver Diseases Therapeutics Drugs Market Size by Application

12 International Players Profiles
12.1 F. Hoffmann-La Roche
12.1.1 F. Hoffmann-La Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Liver Diseases Therapeutics Drugs Introduction
12.1.4 F. Hoffmann-La Roche Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)
12.1.5 F. Hoffmann-La Roche Recent Development
12.2 Gilead Sciences
12.2.1 Gilead Sciences Company Details
12.2.2 Company Description and Business Overview
12.2.3 Liver Diseases Therapeutics Drugs Introduction
12.2.4 Gilead Sciences Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)
12.2.5 Gilead Sciences Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Liver Diseases Therapeutics Drugs Introduction
12.3.4 GlaxoSmithKline Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Liver Diseases Therapeutics Drugs Introduction
12.4.4 Johnson & Johnson Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)
12.4.5 Johnson & Johnson Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Liver Diseases Therapeutics Drugs Introduction
12.5.4 Merck Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)
12.5.5 Merck Recent Development
12.6 Achillion Pharmaceuticals
12.6.1 Achillion Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Liver Diseases Therapeutics Drugs Introduction
12.6.4 Achillion Pharmaceuticals Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)
12.6.5 Achillion Pharmaceuticals Recent Development
12.7 AbbVie
12.7.1 AbbVie Company Details
12.7.2 Company Description and Business Overview
12.7.3 Liver Diseases Therapeutics Drugs Introduction
12.7.4 AbbVie Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)
12.7.5 AbbVie Recent Development
12.8 Angion Biomedica
12.8.1 Angion Biomedica Company Details
12.8.2 Company Description and Business Overview
12.8.3 Liver Diseases Therapeutics Drugs Introduction
12.8.4 Angion Biomedica Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)
12.8.5 Angion Biomedica Recent Development
12.9 Bayer
12.9.1 Bayer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Liver Diseases Therapeutics Drugs Introduction
12.9.4 Bayer Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)
12.9.5 Bayer Recent Development
12.10 LG Life Sciences
12.10.1 LG Life Sciences Company Details
12.10.2 Company Description and Business Overview
12.10.3 Liver Diseases Therapeutics Drugs Introduction
12.10.4 LG Life Sciences Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)
12.10.5 LG Life Sciences Recent Development
12.11 Phenex Pharmaceuticals
12.12 ProMetic Life Sciences
12.13 Raptor Pharmaceuticals
12.14 Shenzhen Kangtai Biological Products
12.15 Verva Pharmaceuticals

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Liver Diseases Therapeutics Drugs Key Market Segments
Table Key Players Liver Diseases Therapeutics Drugs Covered
Table Global Liver Diseases Therapeutics Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Liver Diseases Therapeutics Drugs Market Size Market Share by Type 2014-2025
Figure Oral Figures
Table Key Players of Oral
Figure Injection Figures
Table Key Players of Injection
Table Global Liver Diseases Therapeutics Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Other Case Studies
Figure Liver Diseases Therapeutics Drugs Report Years Considered
Table Global Liver Diseases Therapeutics Drugs Market Size 2014-2025 (Million US$)
Figure Global Liver Diseases Therapeutics Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Liver Diseases Therapeutics Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Liver Diseases Therapeutics Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Liver Diseases Therapeutics Drugs Market Share by Regions 2014-2019
Figure Global Liver Diseases Therapeutics Drugs Market Share by Regions 2014-2019
Figure Global Liver Diseases Therapeutics Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Liver Diseases Therapeutics Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Liver Diseases Therapeutics Drugs Market Share by Manufacturers (2014-2019)
Figure Global Liver Diseases Therapeutics Drugs Market Share by Manufacturers in 2018
Table Global Liver Diseases Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Liver Diseases Therapeutics Drugs Product/Solution/Service
Table Date of Enter into Liver Diseases Therapeutics Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Liver Diseases Therapeutics Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Liver Diseases Therapeutics Drugs Market Size Share by Type (2014-2019)
Figure Global Liver Diseases Therapeutics Drugs Market Size Market Share by Type (2014-2019)
Table Global Liver Diseases Therapeutics Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Liver Diseases Therapeutics Drugs Market Size Share by Application (2014-2019)
Figure Global Liver Diseases Therapeutics Drugs Market Size Market Share by Application (2014-2019)
Figure Global Liver Diseases Therapeutics Drugs Revenue Market Share by Application in 2018
Figure United States Liver Diseases Therapeutics Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Liver Diseases Therapeutics Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Liver Diseases Therapeutics Drugs Market Share (2018-2019)
Table United States Liver Diseases Therapeutics Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Liver Diseases Therapeutics Drugs Market Share by Type (2014-2019)
Table United States Liver Diseases Therapeutics Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Liver Diseases Therapeutics Drugs Market Share by Application (2014-2019)
Figure Europe Liver Diseases Therapeutics Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Liver Diseases Therapeutics Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Liver Diseases Therapeutics Drugs Market Share (2018-2019)
Table Europe Liver Diseases Therapeutics Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Liver Diseases Therapeutics Drugs Market Share by Type (2014-2019)
Table Europe Liver Diseases Therapeutics Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Liver Diseases Therapeutics Drugs Market Share by Application (2014-2019)
Figure China Liver Diseases Therapeutics Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Liver Diseases Therapeutics Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Liver Diseases Therapeutics Drugs Market Share (2018-2019)
Table China Liver Diseases Therapeutics Drugs Market Size by Type (2014-20189) (Million US$)
Table China Liver Diseases Therapeutics Drugs Market Share by Type (2014-2019)
Table China Liver Diseases Therapeutics Drugs Market Size by Application (2014-2019) (Million US$)
Table China Liver Diseases Therapeutics Drugs Market Share by Application (2014-2019)
Figure Japan Liver Diseases Therapeutics Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Liver Diseases Therapeutics Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Liver Diseases Therapeutics Drugs Market Share (2018-2019)
Table Japan Liver Diseases Therapeutics Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Liver Diseases Therapeutics Drugs Market Share by Type (2014-2019)
Table Japan Liver Diseases Therapeutics Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Liver Diseases Therapeutics Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Liver Diseases Therapeutics Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Liver Diseases Therapeutics Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Liver Diseases Therapeutics Drugs Market Share (2018-2019)
Table Southeast Asia Liver Diseases Therapeutics Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Liver Diseases Therapeutics Drugs Market Share by Type (2014-2019)
Table Southeast Asia Liver Diseases Therapeutics Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Liver Diseases Therapeutics Drugs Market Share by Application (2014-2019)
Figure India Liver Diseases Therapeutics Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Liver Diseases Therapeutics Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Liver Diseases Therapeutics Drugs Market Share (2018-2019)
Table India Liver Diseases Therapeutics Drugs Market Size by Type (2014-2019) (Million US$)
Table India Liver Diseases Therapeutics Drugs Market Share by Type (2014-2019)
Table India Liver Diseases Therapeutics Drugs Market Size by Application (2014-2019) (Million US$)
Table India Liver Diseases Therapeutics Drugs Market Share by Application (2014-2019)
Figure Central & South America Liver Diseases Therapeutics Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Liver Diseases Therapeutics Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Liver Diseases Therapeutics Drugs Market Share (2018-2019)
Table Central & South America Liver Diseases Therapeutics Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Liver Diseases Therapeutics Drugs Market Share by Type (2014-2019)
Table Central & South America Liver Diseases Therapeutics Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Liver Diseases Therapeutics Drugs Market Share by Application (2014-2019)
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019) (Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)(Million US$)
Figure Gilead Sciences Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2014-2019)
Table Gilead Sciences Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Merck Company Details
Table Merck Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2014-2019)
Table Merck Recent Development
Table Achillion Pharmaceuticals Company Details
Table Achillion Pharmaceuticals Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)(Million US$)
Figure Achillion Pharmaceuticals Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2014-2019)
Table Achillion Pharmaceuticals Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2014-2019)
Table AbbVie Recent Development
Table Angion Biomedica Company Details
Table Angion Biomedica Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)(Million US$)
Figure Angion Biomedica Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2014-2019)
Table Angion Biomedica Recent Development
Table Bayer Company Details
Table Bayer Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2014-2019)
Table Bayer Recent Development
Table LG Life Sciences Company Details
Table LG Life Sciences Revenue in Liver Diseases Therapeutics Drugs Business (2014-2019)(Million US$)
Figure LG Life Sciences Revenue Growth Rate in Liver Diseases Therapeutics Drugs Business (2014-2019)
Table LG Life Sciences Recent Development
Table Phenex Pharmaceuticals Company Details
Table ProMetic Life Sciences Company Details
Table Raptor Pharmaceuticals Company Details
Table Shenzhen Kangtai Biological Products Company Details
Table Verva Pharmaceuticals Company Details
Table Global Liver Diseases Therapeutics Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Liver Diseases Therapeutics Drugs Market Size Share by Regions (2019-2025)
Figure Global Liver Diseases Therapeutics Drugs Market Size Share by Regions in 2025
Figure United States Liver Diseases Therapeutics Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Liver Diseases Therapeutics Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Liver Diseases Therapeutics Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Liver Diseases Therapeutics Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Liver Diseases Therapeutics Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Liver Diseases Therapeutics Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Liver Diseases Therapeutics Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Liver Diseases Therapeutics Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Liver Diseases Therapeutics Drugs Market Size by Product (2019-2025)
Figure Global Liver Diseases Therapeutics Drugs Market Size by Product in 2025
Table Global Liver Diseases Therapeutics Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Liver Diseases Therapeutics Drugs Market Size by Application (2019-2025)
Figure Global Liver Diseases Therapeutics Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---